International Clinical Trial: Prospective, single-arm, multicenter clinical study of rituximab combined with cyclophosphamide, mitoxantrone liposomes, vincristine, and prednisone (R-CMOP) regimen in the treatment of previously untreated diffuse large B-cell lymphoma in patients aged 60 years or older or with underlying heart disease

Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117000) titled 'Prospective, single-arm, multicenter clinical study of rituximab combined with cyclophosphamide, mitoxantrone liposomes, vincristine, and prednisone (R-CMOP) regimen in the treatment of previously untreated diffuse large B-cell lymphoma in patients aged 60 years or older or with underlying heart disease' on Jan. 19.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The First Affiliated Hospital, College of Medicine, Zhejiang University

Condition: Diffuse large B-cell lymphoma

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-01-21

Target Sample Size: ...